In Re: Purdue Pharma L.P.
| Purdue Pharma L.P., Avrio Health L.P., Quidnick Land L.P., Rhodes Technologies, SVC Pharma LP, Adlon Therapeutics L.P., Rhodes Pharmaceuticals L.P., Purdue Neuroscience Company, Rhodes Associates L.P., Greenfield BioVentures L.P., Nayatt Cove Lifescience Inc., Purdue Pharma Manufacturing L.P., Purdue Pharma of Puerto Rico, Ophir Green Corp., Paul Land Inc., Button Land L.P., Purdue Pharmaceuticals L.P., Purdue Pharma Inc., Purdue Pharmaceutical Products L.P., Purdue Transdermal Technologies L.P., UDF LP, SVC Pharma Inc., Imbrium Therapeutics L.P. and Seven Seas Hill Corp. |
| Collegium Pharmaceutical, Inc. |
| 7:2020cv07942 |
| September 25, 2020 |
| US District Court for the Southern District of New York |
| Vincent L Briccetti |
| Bankruptcy Appeal (801) |
| 28 U.S.C. § 0158 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 19, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Magistrate Judge Andrew E. Krause is so redesignated. (laq) |
| Filing 18 NOTICE OF RECORD OF APPEAL AVAILABILITY (COMPLETION). Re: #1 Bankruptcy Appeal,. All Documents from the United States Bankruptcy Court - Southern District of New York have been filed with the U.S.D.C. S.D.N.Y. Record of Appeal is Complete and Available Electronically. Appellant Brief due by 11/16/2020. (bkar) |
| Filing 17 COUNTER DESIGNATION OF BANKRUPTCY RECORD ON APPEAL Document filed by Appellee Purdue Pharmaceuticals L.P. (bkar) |
Filing 16
ORDER granting #7 Motion to Stay: Upon consideration of the parties' papers and arguments, Appellant's Unopposed Motion to Stay Appeal is hereby granted in its entirety, and the instant appeal, including all deadlines associated therewith, is stayed pending the outcome of the Post Grant Review, PGR2018-00048, concerning U.S. Patent No. 9,693,961 in the Patent Trial and Appeal Board, and any appeal taken therefrom. By 1/14/2021, and every 90 days thereafter, the parties shall submit a joint status report regarding the Post Grant Review and any appeal taken therefrom. (HEREBY ORDERED by Judge Vincent L. Briccetti)(Text Only Order) (pp) Transmission to Office of the Clerk of Court for processing. Transmission to US Bankruptcy Court-Southern District of New York for processing.
|
| Filing 15 NOTICE OF APPEARANCE by Christopher Scott Robertson on behalf of Adlon Therapeutics L.P., Avrio Health L.P., Button Land L.P., Greenfield BioVentures L.P., Imbrium Therapeutics L.P., Nayatt Cove Lifescience Inc., Ophir Green Corp., Paul Land Inc., Purdue Neuroscience Company, Purdue Pharma Inc., Purdue Pharma L.P., Purdue Pharma Manufacturing L.P., Purdue Pharma of Puerto Rico, Purdue Pharmaceutical Products L.P., Purdue Pharmaceuticals L.P., Purdue Transdermal Technologies L.P., Quidnick Land L.P., Rhodes Associates L.P., Rhodes Pharmaceuticals L.P., Rhodes Technologies, SVC Pharma Inc., SVC Pharma LP, Seven Seas Hill Corp., UDF LP..(Robertson, Christopher) |
| Filing 14 NOTICE OF APPEARANCE by Eli James Vonnegut on behalf of Adlon Therapeutics L.P., Avrio Health L.P., Button Land L.P., Greenfield BioVentures L.P., Imbrium Therapeutics L.P., Nayatt Cove Lifescience Inc., Ophir Green Corp., Paul Land Inc., Purdue Neuroscience Company, Purdue Pharma Inc., Purdue Pharma L.P., Purdue Pharma Manufacturing L.P., Purdue Pharma of Puerto Rico, Purdue Pharmaceutical Products L.P., Purdue Pharmaceuticals L.P., Purdue Transdermal Technologies L.P., Quidnick Land L.P., Rhodes Associates L.P., Rhodes Pharmaceuticals L.P., Rhodes Technologies, SVC Pharma Inc., SVC Pharma LP, Seven Seas Hill Corp., UDF LP..(Vonnegut, Eli) |
| Filing 13 NOTICE OF APPEARANCE by Marc Joseph Tobak on behalf of Adlon Therapeutics L.P., Avrio Health L.P., Button Land L.P., Greenfield BioVentures L.P., Imbrium Therapeutics L.P., Nayatt Cove Lifescience Inc., Ophir Green Corp., Paul Land Inc., Purdue Neuroscience Company, Purdue Pharma Inc., Purdue Pharma L.P., Purdue Pharma Manufacturing L.P., Purdue Pharma of Puerto Rico, Purdue Pharmaceutical Products L.P., Purdue Pharmaceuticals L.P., Purdue Transdermal Technologies L.P., Quidnick Land L.P., Rhodes Associates L.P., Rhodes Pharmaceuticals L.P., Rhodes Technologies, SVC Pharma Inc., SVC Pharma LP, Seven Seas Hill Corp., UDF LP..(Tobak, Marc) |
| Filing 12 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent UDF L.P. for Button Land L.P., Quidnick Land L.P., SVC Pharma LP; Corporate Parent Purdue Pharma L.P. for Adlon Therapeutics L.P., Avrio Health L.P., Greenfield BioVentures L.P., Imbrium Therapeutics L.P., Nayatt Cove Lifescience Inc., Ophir Green Corp., Purdue Neuroscience Company, Purdue Pharma Manufacturing L.P., Purdue Pharmaceutical Products L.P., Purdue Pharmaceuticals L.P., Purdue Transdermal Technologies L.P., Rhodes Associates L.P., Seven Seas Hill Corp.; Corporate Parent Pharmaceutical Research Associates L.P., Corporate Parent PLP Associates Holdings L.P., Corporate Parent BR Holdings Associates L.P., Corporate Parent Beacon Company, Other Affiliate Jonathan D. Sackler, Other Affiliate Rosebay Medical Company L.P., Other Affiliate Heatheridge Trust Company Limited, Other Affiliate Richard S. Sackler, M.D. for Purdue Pharma L.P.; Corporate Parent Rhodes Associates L.P. for Paul Land Inc., Rhodes Pharmaceuticals L.P., Rhodes Technologies; Corporate Parent Rhodes Technologies for SVC Pharma Inc., UDF LP ; Other Affiliate Banela Corporation, Other Affiliate Linarite Holdings LLC, Other Affiliate Perthlite Holdings LLC, Other Affiliate Millborne Trust Company Limited, Other Affiliate Data LLC, Other Affiliate Cornice Fiduciary Management LLC, for Purdue Pharma Inc.. Document filed by Adlon Therapeutics L.P., Avrio Health L.P., Button Land L.P., Greenfield BioVentures L.P., Imbrium Therapeutics L.P., Nayatt Cove Lifescience Inc., Ophir Green Corp., Paul Land Inc., Purdue Neuroscience Company, Purdue Pharma Inc., Purdue Pharma L.P., Purdue Pharma Manufacturing L.P., Purdue Pharma of Puerto Rico, Purdue Pharmaceutical Products L.P., Purdue Pharmaceuticals L.P., Purdue Transdermal Technologies L.P., Quidnick Land L.P., Rhodes Associates L.P., Rhodes Pharmaceuticals L.P., Rhodes Technologies, SVC Pharma Inc., SVC Pharma LP, Seven Seas Hill Corp., UDF LP..(Kaminetzky, Benjamin) |
| Filing 11 NOTICE OF APPEARANCE by Benjamin S. Kaminetzky on behalf of Adlon Therapeutics L.P., Avrio Health L.P., Button Land L.P., Greenfield BioVentures L.P., Imbrium Therapeutics L.P., Nayatt Cove Lifescience Inc., Ophir Green Corp., Paul Land Inc., Purdue Neuroscience Company, Purdue Pharma Inc., Purdue Pharma L.P., Purdue Pharma Manufacturing L.P., Purdue Pharma of Puerto Rico, Purdue Pharmaceutical Products L.P., Purdue Pharmaceuticals L.P., Purdue Transdermal Technologies L.P., Quidnick Land L.P., Rhodes Associates L.P., Rhodes Pharmaceuticals L.P., Rhodes Technologies, SVC Pharma Inc., SVC Pharma LP, Seven Seas Hill Corp., UDF LP..(Kaminetzky, Benjamin) |
| Filing 10 RESPONSE to Motion re: #7 MOTION to Stay Appeal. . Document filed by Purdue Pharma L.P., Purdue Pharma Inc., Purdue Transdermal Technologies L.P., Purdue Pharma Manufacturing L.P., Purdue Pharmaceuticals L.P., Imbrium Therapeutics L.P., Adlon Therapeutics L.P., Greenfield BioVentures L.P., Seven Seas Hill Corp., Ophir Green Corp., Purdue Pharma of Puerto Rico, Avrio Health L.P., Purdue Pharmaceutical Products L.P., Purdue Neuroscience Company, Nayatt Cove Lifescience Inc., Button Land L.P., Rhodes Associates L.P., Paul Land Inc., Quidnick Land L.P., Rhodes Pharmaceuticals L.P., Rhodes Technologies, UDF LP, SVC Pharma LP, SVC Pharma Inc...(Kaminetzky, Benjamin) |
| Filing 9 PROPOSED ORDER. Document filed by Collegium Pharmaceutical, Inc.. Related Document Number: #7 ..(Langer, Oren) Proposed Order to be reviewed by Clerk's Office staff. |
| Filing 8 MEMORANDUM OF LAW in Support re: #7 MOTION to Stay Appeal. . Document filed by Collegium Pharmaceutical, Inc...(Langer, Oren) |
| Filing 7 MOTION to Stay Appeal. Document filed by Collegium Pharmaceutical, Inc...(Langer, Oren) |
| ***NOTICE TO COURT REGARDING PROPOSED ORDER. Document No. #9 Proposed Order was reviewed and approved as to form. (km) |
| ***NOTICE TO ATTORNEY TO RE-FILE DOCUMENT - DEFICIENT DOCKET ENTRY ERROR. Notice to Attorney Oren Dov Langer to RE-FILE Document #6 MOTION to Stay Appeal.. ERROR(S): Supporting Documents Must Be Filed Separately. (lb) |
| Filing 6 FILING ERROR - DEFICIENT DOCKET ENTRY - (SUPPORTING DOCUMENTS TO BE FILED SEPARATELY) - MOTION to Stay Appeal. Document filed by Collegium Pharmaceutical, Inc.. (Attachments: #1 Memorandum of Law, #2 Proposed Order).(Langer, Oren) Modified on 10/6/2020 (lb). |
| Filing 5 NOTICE OF APPEARANCE by Oren Dov Langer on behalf of Collegium Pharmaceutical, Inc...(Langer, Oren) |
| Filing 4 DESIGNATION OF BANKRUPTCY RECORD ON APPEAL re: #1 Bankruptcy Appeal,. Document filed by Appellant Collegium Pharmaceutical, Inc.. (bkar) |
|
Filing 3
ORDER: The above-captioned bankruptcy appeal having been docketed in the District Court on September 25, 2020 (Doc. #1), it is hereby ORDERED: 1. The briefing schedule and format and length specifications set forth in the applicable provisions of Federal Rules of Bankruptcy Procedure 8015 through 8018 apply unless otherwise ordered by the Court. 2. The parties shall promptly provide to the Court a suitably bound courtesy copy of the Joint Appendix or other compilation(s) comprising the documents designated for the record on appeal, as well as courtesy copies of their briefs and other filings in connection with the appeal. 3. A conference will be held herein on October 30, 2020, at 9:30 a.m. Counsel shall attend by calling the following number and entering the access code when requested: Number: (888) 363-4749 (toll-free) or (215) 446-3662 Access Code: 1703567. 4. Counsel for the parties shall confer at least 14 days prior to the date set forth in paragraph 3 to discuss the following matters: (i) settlement; (ii) whether mediation might facilitate resolution of the issues; and (iii) a schedule for any further submissions that may be required in connection with the appeal. Counsel must be prepared to discuss the foregoing at the conference. 5. Counsel attending the conference must seek settlement authority from their respective clients prior to such conference. If counsel is not granted such authority, the client must be present in person or available by telephone so that a settlement can be consummated if possible. SO ORDERED. Telephone Conference set for 10/30/2020 at 09:30 AM before Judge Vincent L. Briccetti. (Signed by Judge Vincent L. Briccetti on 9/29/2020) (mml)
|
| Filing 2 CIVIL COVER SHEET filed. (bkar) |
| Filing 1 NOTICE OF APPEAL FROM THE BANKRUPTCY COURT TO THE S.D.N.Y. from the Order of Judge Robert D. Drain dated September 1, 2020. Bankruptcy Court Case Numbers: 19-B-23649 (RDD). Certified copies of file received.Document filed by Collegium Pharmaceutical, Inc.(bkar) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
